Cargando…
Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
Autores principales: | Shaker, Marcus S., Oppenheimer, John, Grayson, Mitchell, Stukus, David, Hartog, Nicholas, Hsieh, Elena W.Y., Rider, Nicholas, Dutmer, Cullen M., Vander Leek, Timothy K., Kim, Harold, Chan, Edmond S., Mack, Doug, Ellis, Anne K., Lang, David, Lieberman, Jay, Fleischer, David, Golden, David B.K., Wallace, Dana, Portnoy, Jay, Mosnaim, Giselle, Greenhawt, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174169/ https://www.ncbi.nlm.nih.gov/pubmed/32340824 http://dx.doi.org/10.1016/j.jaip.2020.04.016 |
Ejemplares similares
-
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic
por: Shaker, Marcus S., et al.
Publicado: (2020) -
A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services
por: Searing, Daniel A., et al.
Publicado: (2020) -
Health and Economic Outcomes of Home Maintenance Allergen Immunotherapy in Select Patients with High Health Literacy during the COVID-19 Pandemic: A Cost-Effectiveness Analysis During Exceptional Times
por: Shaker, Marcus S., et al.
Publicado: (2020) -
Subcutaneous terbutaline as an alternative to aerosolized albuterol
por: Strauss, Ronald A.
Publicado: (2020) -
Reply to “Challenges to pediatric services during COVID-19 pandemic: A London, UK perspective”
por: Bansal, Priya, et al.
Publicado: (2020)